Why the Elixinol (ASX:EXL) share price has been halted today?

The Elixinol (ASX:EXL) share price remains in a trading halt today as the company plans a potential transaction. We take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Elixinol Global Ltd (ASX: EXL) share price has been halted today as the company reported that it would be announcing a potential transaction.

Shares in the small-cap cannabis company have not been trading since the start of today. Consequently, the Elixinol share price remains at 19.5 cents.

ASX share price trading halt represented by serious woman putting hand up

Image source: Getty Images

What happened to Elixinol

The Elixinol share price will be one to watch in the coming days as its shares begin trading again. According to the release, the trading halt will remain in place until the announcement. Alternatively, when trading commences on March 8. Whatever is earlier.

The potential transaction is yet to be announced. Elixinol has stated that it wasn't aware of any reason why the halt should not be granted. 

Full year results

Notably, the company recently released its full-year results on February 26. Its shares have since nosedived, shedding around 9%.

Elixinol highlighted its global reset strategy. This has been put in place to stabilise its share price. For reference, the Elixinol share price has dropped an astounding 95.7% since May 2019. According to the company, the strategy has resulted in a strong balance sheet being formed. Ultimately, with lower costs and new growth catalysts. On this note, the cash at hand was $27.7 million at the time of reporting.
 
Furthermore, there was a significant margin improvement in the second half of FY2020. This comes as its business plan continues to shift more towards online and e-commerce. A sector with significant tailwinds.
 
Elixinol CEO Oliver Horn addressed the results saying:
While much of the past 12 months has been challenging for traditional retailers, we made great strides forward in our pursuit of sustainable growth and improved capital efficiency. Our strategy to reduce our cost base and shift the business towards higher margin channels, while bringing new products to market and entering new categories, is starting to show success via an improving bottom-line.
Mr. Horn also claimed the company is in a good position to benefit from the growing consumer trend for hemp wellbeing products. Despite his positive sentiment the market has struggled to make headway, falling 9% since the release.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »